Ju Fu Tang Biotech Holdings Co 8217.HK · HKD

Industrials · HKEX · 🇭🇰 Hong Kong

Compare

0.09

0.00%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2026

Revenue

HK$37.6m

FY2017FY2026

Net income

HK$23.3m

FY2017FY2026

Free cash flow

HK$7.8m

FY2017FY2026

Shareholders' equity

HK$50.5m

FY2017FY2026

Income statement

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenue	HK$37.6m	HK$36.2m	HK$35.1m	HK$104.6m	HK$92.8m	HK$168.3m	HK$354.9m	HK$432.8m	HK$708.6m	HK$735.3m
Gross profit	HK$1.0m	HK$982,000	HK$1.9m	−HK$2.9m	HK$1.0m	−HK$2.3m	−HK$20.2m	HK$1.1m	HK$17.8m	HK$58.0m
Operating income	−HK$6.2m	−HK$5.2m	−HK$16.7m	−HK$9.2m	−HK$19.5m	−HK$15.2m	−HK$56.3m	−HK$6.5m	−HK$2.4m	HK$38.4m
Net income	HK$23.3m	−HK$5.9m	−HK$17.4m	−HK$10.0m	−HK$20.1m	−HK$13.1m	−HK$55.6m	−HK$6.0m	−HK$2.9m	HK$30.5m
Diluted earnings per share	0.08	-0.02	-0.06	-0.03	-0.07	-0.10	-0.59	-0.07	-0.03	0.34

Balance sheet

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Total assets	HK$92.6m	HK$80.4m	HK$81.6m	HK$105.5m	HK$144.3m	HK$163.2m	HK$215.1m	HK$263.0m	HK$348.3m	HK$210.9m
Cash and short-term investments	HK$60.7m	HK$30.2m	HK$26.7m	HK$44.2m	HK$44.7m	HK$47.7m	HK$20.9m	HK$44.7m	HK$139.0m	HK$23.0m
Total liabilities	HK$42.1m	HK$53.1m	HK$48.4m	HK$55.0m	HK$83.8m	HK$138.4m	HK$183.9m	HK$180.5m	HK$244.8m	HK$104.6m
Debt	HK$12.0m	HK$12.0m	HK$12.0m	HK$12.0m	HK$12.2m	HK$12.4m	HK$17.5m	HK$24.0m	HK$39.8m	HK$6.5m
Shareholders' equity	HK$50.5m	HK$27.2m	HK$33.1m	HK$50.5m	HK$60.5m	HK$24.8m	HK$31.2m	HK$82.5m	HK$103.5m	HK$106.4m
Shares outstanding	303m	302m	302m	302m	302m	135m	94m	89m	89m	89m

Cash flow

Fiscal years

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Cash from operations	HK$7.8m	−HK$7.3m	HK$3.7m	HK$32.2m	−HK$19.5m	HK$28.5m	−HK$21.0m	−HK$76.7m	−HK$43.6m	HK$49,000
Capital spending	—	—	—	−HK$33.2m	−HK$17.1m	—	−HK$3,000	−HK$1.2m	−HK$7.3m	−HK$28.0m
Free cash flow	HK$7.8m	−HK$7.3m	HK$3.7m	−HK$950,000	−HK$36.7m	HK$28.5m	−HK$21.0m	−HK$77.9m	−HK$50.9m	−HK$28.0m

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	-28.9%	-25.9%	-19.2%
Operating income	-12.6%	-16.6%	—
Net income	—	—	10.8%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	2.7%	0.5%	-0.1%	2.7%
Operating margin	-15.4%	-17.5%	-15.2%	-2.9%
Net margin	23.6%	-4.7%	-9.1%	-2.3%

Valuation history

At each fiscal year end

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Price to earnings	1.1	-19.2	-5.5	-3.6	-1.7	-2.4	-0.9	-11.8	-50.9	12.3
Price to sales	0.7	3.1	2.7	0.3	0.4	0.2	0.1	0.2	0.2	0.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

4-to-1 reverse split · 13 Sept 2021
4-to-1 reverse split · 18 Mar 2020

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Ju Fu Tang Biotech Holdings Co 8217.HK · HKD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology